Tick repellents I: Ethylene glycol acetamides

Effect of BAY U 3405, a new thromboxane antagonist, on sudden death in rabbits.

Journal of lipid mediators·1991

Characterization of Bay U 3405, a novel thromboxane A2/endoperoxide receptor antagonist.

Stroke·1990

Reduction of in vivo coronary artery thrombosis by the novel thromboxane antagonist (3R)-3-(4-fluorophenylsulfonamido)-1,2,3,4-tetrahydro-9- carbazolepropanoic acid.

Arzneimittel-Forschung·1989

Inhibition of platelet aggregation in vitro and ex vivo by the new thromboxane antagonist (3R)-3-(4-fluorophenylsulfonamido)-1,2,3,4-tetrahydro-9- carbazolepropanoic acid.

Arzneimittel-Forschung·1989

Action of the novel selective thromboxane antagonist (3R)-3-(4-fluorophenylsulfonamido)-1,2,3,4-tetrahydro-9-carbazolepropan oic acid on vascular smooth muscle preparations.

Arzneimittel-Forschung·1989

Synthesis and absolute configuration of the new thromboxane antagonist (3R)-3-(4-fluorophenylsulfonamido)-1,2,3,4-tetrahydro-9-carbazolepropan oic acid and comparison with its enantiomer.

Arzneimittel-Forschung·1989

The use of the enzyme chitosanase to enable vaccine potency determination in a formulation containing the adjuvant chitosan.

Journal of pharmaceutical sciences·2026

The impact of silicone oil on the formation of free fatty acids particles.

Journal of pharmaceutical sciences·2026

Eco-friendly stability-indicating HPLC method development, validation, and LC-MS-based characterization of degradation products of the polar drug imeglimin.

Journal of pharmaceutical sciences·2026

Experimental and computational study of pMDI aerosol delivery in mucus-coated pediatric airways: Effects of inhalation flow and actuation timing.

Journal of pharmaceutical sciences·2026

Pharmaceutical assessment of low global warming potential alternatives to HFA-134a in a budesonide, glycopyrrolate, and formoterol fumarate pressurized metered dose inhaler.

Journal of pharmaceutical sciences·2026

Biophysical investigations into the impact of crystallization conditions on monoclonal antibody properties and purification.

Journal of pharmaceutical sciences·2026

Inducing Metabolic Dysfunction in Breast Cancer Cells Through Targeted Inhibition of α- and β-Glucosidase and Amylase: Novel Carbohydrate (C8N) Isomers Designed via Intramolecular aza-Michael-Type Reaction.

ChemMedChem·2026

Structural and Biophysical Characterization of C-Glycosylic 1,2-Thiodisaccharides Reveals Determinants of Selective Binding to Galectin-7 and Galectin-8N.

ChemMedChem·2026

Route-selective enzymatic synthesis and structural elucidation of monooctanoylgalloylglycerols as amphiphilic phenolic structured lipids.

Current research in food science·2026

Insights into glucomoringin biosynthesis in moringa sprouts through integrated transcriptomic and metabolomic analyses.

Food chemistry. Molecular sciences·2026

Correction to: Clonal interference and changing selective pressures shape the escape of SARS-CoV-2 from hundreds of antibodies.

Virus evolution·2026

A multifunctional lactose-containing molecule: Structural characterization, biocompatibility and host-guest complexation studies toward drug delivery applications.

Carbohydrate research·2026

Related Experiment Videos

Tick repellents I: Ethylene glycol acetamides

Related Concept Videos

Effect of BAY U 3405, a new thromboxane antagonist, on sudden death in rabbits.

Characterization of Bay U 3405, a novel thromboxane A2/endoperoxide receptor antagonist.

Reduction of in vivo coronary artery thrombosis by the novel thromboxane antagonist (3R)-3-(4-fluorophenylsulfonamido)-1,2,3,4-tetrahydro-9- carbazolepropanoic acid.

Inhibition of platelet aggregation in vitro and ex vivo by the new thromboxane antagonist (3R)-3-(4-fluorophenylsulfonamido)-1,2,3,4-tetrahydro-9- carbazolepropanoic acid.

Action of the novel selective thromboxane antagonist (3R)-3-(4-fluorophenylsulfonamido)-1,2,3,4-tetrahydro-9-carbazolepropan oic acid on vascular smooth muscle preparations.

Synthesis and absolute configuration of the new thromboxane antagonist (3R)-3-(4-fluorophenylsulfonamido)-1,2,3,4-tetrahydro-9-carbazolepropan oic acid and comparison with its enantiomer.

The use of the enzyme chitosanase to enable vaccine potency determination in a formulation containing the adjuvant chitosan.

The impact of silicone oil on the formation of free fatty acids particles.

Eco-friendly stability-indicating HPLC method development, validation, and LC-MS-based characterization of degradation products of the polar drug imeglimin.

Experimental and computational study of pMDI aerosol delivery in mucus-coated pediatric airways: Effects of inhalation flow and actuation timing.

Pharmaceutical assessment of low global warming potential alternatives to HFA-134a in a budesonide, glycopyrrolate, and formoterol fumarate pressurized metered dose inhaler.

Biophysical investigations into the impact of crystallization conditions on monoclonal antibody properties and purification.

Inducing Metabolic Dysfunction in Breast Cancer Cells Through Targeted Inhibition of α- and β-Glucosidase and Amylase: Novel Carbohydrate (C8N) Isomers Designed via Intramolecular aza-Michael-Type Reaction.

Structural and Biophysical Characterization of C-Glycosylic 1,2-Thiodisaccharides Reveals Determinants of Selective Binding to Galectin-7 and Galectin-8N.

Route-selective enzymatic synthesis and structural elucidation of monooctanoylgalloylglycerols as amphiphilic phenolic structured lipids.

Insights into glucomoringin biosynthesis in moringa sprouts through integrated transcriptomic and metabolomic analyses.

Correction to: Clonal interference and changing selective pressures shape the escape of SARS-CoV-2 from hundreds of antibodies.

A multifunctional lactose-containing molecule: Structural characterization, biocompatibility and host-guest complexation studies toward drug delivery applications.

Related Experiment Videos

Tick repellents I: Ethylene glycol acetamides

Related Concept Videos

Related Articles